This site is intended for healthcare professionals

Are COVID-19 vaccines effective against long Covid?

Time : 8th of December 2022 11:40:20 AM Physician/Medicine,Pharma News,Covid-19

A meta-analysis revealed that one or more doses of COVID-19 vaccines are 29% effective in preventing symptoms that last for three weeks or more after infection. People who received the vaccine after infection also experienced some benefits. These findings might encourage and reassure unvaccinated people with persistent symptoms to get vaccinated.

Rebound of COVID-19 after Paxlovid treatment is rare

Time : 7th of December 2022 01:05:16 PM Physician/Medicine,Pharma News,Covid-19

A study from Hong Kong on hospitalized patients with COVID-19 revealed the rebound of the virus infection after treatment with Paxlovid ( nirmatrelvir-ritonavir) and molnupiravir was uncommon. It also showed these treatments were not associated with higher chances of mortality. These findings suggest using these treatments for treating patients with early COVID-19 infection.

New malaria drug should be given at higher doses to cure infection

Time : 7th of December 2022 12:31:14 PM Physician/Medicine,Pharma News

Tafenoquine at a dose of 300 mg was found to reduce recurrent infections with Plasmodium vivax by 70%, as per a study. Increasing the dose to 450 mg also reduced the recurrence by 85%. The drug has the advantage of being single-dosed, unlike primaquine, which should be taken for 7 to 14 days. Some studies suggested that a 300 mg dose of the drug was inferior to primaquine.
  Today UK News

Pneumococcal conjugate vaccines could reduce pneumonia hospitalizations

Time : 7th of December 2022 09:44:53 AM Pulmonology,Physician/Medicine,Pharma News

Older adults aged above 65 years who received the 13-valent pneumococcal conjugate vaccine were at a 6.7% lower risk of hospitalization due to pneumonia compared to those who did not take it, as per a study. The risk was 5.8% to 7.5% lower in older adults with underlying health conditions. Vaccine beneficiaries received the vaccine 14 days or more before hospitalization.
  Twitter @JAMAInternalMed

Elon Musk's Neuralink is under investigation for violations

Time : 6th of December 2022 10:35:30 AM Physician/Medicine,Pharma News,Neurology & Neurosurgery,Entertainment

Internal staff complaints of animal-welfare violations leading to needless suffering and deaths have caused federal investigation, according to sources. The employees also complained that the rush to develop products led to botched experiments. The firm is developing brain implants that target paralyzed people and those with neurological diseases.
  Twitter @Reuters_Health

BCG vaccine in infancy protects against TB in children but not adults

Time : 6th of December 2022 09:59:24 AM Pulmonology,Physician/Medicine,Pharma News,Paediatrics

A study showed that BCG vaccination given at birth does not provide significant protection against tuberculosis among adults or adolescents. However, it protected children under the age of 5 years. These findings suggest that the vaccine's effectiveness begins to wave at 10 years of age, and adults should get booster shots for further protection against tuberculosis.

FDA retrieves authorization for Eli Lily's COVID-19 drug bebtelovimab

Time : 5th of December 2022 10:36:45 AM Physician/Medicine,Pharma News,Covid-19

The antibody therapy is not expected to work against Omicron subvariants BQ.1 and BQ.1.1. The firm has already paused the distribution of the drug. The FDA suggested that physicians use other drugs that are expected to work against these subvariants, including Paxlovid, Veklury, and Lagevrio. High titers of convalescent plasma is also advised for people with immune diseases.

FDA approves fecal transplant treatment for the first time

Time : 1st of December 2022 01:12:44 PM Physician/Medicine,Pharma News,Gastroenterology

Rebyota from Ferring Pharmaceuticals targets Clostridium difficile for severe diarrhoea. It is given as an enema, and it replenishes good bacteria in the gut. The good gut bacteria is taken from fecal samples of healthy donors. The treatment availability and pricing are not yet known. Seres Therapeutics and other firms are also developing similar oral treatments.
  Twitter @Reuters_Health

A new material to heal diabetic wounds faster

Time : 1st of December 2022 12:11:15 PM Physician/Medicine,Pharma News,Endocrinology & Diabetes

Researchers discovered a polymer that can instruct immune and fibroblast cells to help heal hard-to-treat diabetic wounds. The polymer can be applied directly to diabetic wounds. A single application of this polymer to the wounds in animal models increased fibroblast activity by three times in just four days and caused 80% wound closure, as per the study.
  University of Nottingham

TikTok trend causes a shortage of a diabetes medication

Time : 1st of December 2022 10:34:19 AM Physician/Medicine,Pharma News,Nutrition & Fitness,Endocrinology & Diabetes

Ozempic is a weekly injection that will help patients with type 2 diabetes improve their insulin sensitivity and suppress appetite, causing weight loss. Some celebrities started using it to shed weight, which sparked people's interest. Now the demand for this drug is causing shortages and harm to needy patients. Another weight loss drug Wegovy's supply also reduced.
  USA Today